The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Open accessAbstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Several lines of evidence strongly implicate mitochondrial dysfunction as a major causative factor in PD, although the molecular mechanisms responsible for mitochondrial dysfunction are poorly understood. Recently, loss-of-function mutations in the parkin gene, which encodes a ubiquitin-protein ligase, were found to underlie a familial form of PD known as autosomal recessive juvenile parkinsonism (AR-JP). To gain insight into the molecular mechanism responsible for selective cell death in AR-JP, we have created a Drosophila model of this disorder. Drosophila parkin null mutants exhibit reduced lifespan, locomotor defects, and male sterility. The locomotor defects derive from apoptotic cell death of muscle subsets, whereas the male sterile phenotype derives from a spermatid individualization defect at a late stage of spermatogenesis. Mitochondrial pathology is the earliest manifestation of muscle degeneration and a prominent characteristic of individualizing spermatids in parkin mutants. These results indicate that the tissue-specific phenotypes observed in Drosophila parkin mutants result from mitochondrial dysfunction and raise the possibility that similar mitochondrial impairment triggers the selective cell loss observed in AR-JP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, reduction of mitophagy caused by the ablation of PINK and Parkin induces mitochondrial dysfunction and increased sensitivity to oxidative stress followed by muscle degeneration [225–228].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [225]
In the citing paper
“Both excessive autophagy [140, 186] and the deficient degradation of cytosolic components [225, 226] contribute to muscle atrophy.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [225]
In the citing paper
“whereas Parkin loss-of-function in Drosophila resulted in a decreased lifespan and increased locomotor defects [157,158].”
From Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging (2021) · cites this paper as [157]
In the citing paper
“Although there are conflicting data regarding the specific effects of these proteins on mitochondrial morphology in mammalian cells, extensive studies in Drosophila revealed that knocking out either gene caused muscle degeneration that was associated with enlarged mitochondria (Clark et al., 2006; Greene et al., 2003).”
From New insights into the role of mitochondria in aging: mitochondrial dynamics and more (2010) · cites this paper as Greene et al., 2003
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,510
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Self-citationFamilial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,000
Genetic elevation of Sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila
Pantoja, M., Fischer, K. A., Ieronimakis, N. M., Reyes, M., & Ruohola‐Baker, H. (2012) · Development · doi:10.1242/dev.087791 · Cited by 36
Shimura, T., Sasatani, M., Kawai, H., Kamiya, K., Kobayashi, J., Komatsu, K., & Kunugita, N. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1284716 · Cited by 41
Pareek, G., Thomas, R. E., Vincow, E. S., Morris, D. R., & Pallanck, L. J. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0110-1 · Cited by 37
Self-citationAntioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster
Lazzari, F. D., Sandrelli, F., Whitworth, A. J., & Bisaglia, M. (2020) · Antioxidants · doi:10.3390/antiox9010052 · Cited by 36
Self-citationvan der Vlag, M., Havekes, R., & Heckman, P. R. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14689 · Cited by 37
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Evaluation of Traditional Medicines for Neurodegenerative Diseases Using Drosophila Models
Lee, S., Bang, S. M., Lee, J. W., & Cho, K. S. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/967462 · Cited by 36
RBR Ubiquitin Ligases: Diversification and Streamlining in Animal Lineages
Marı́n, I. (2009) · Journal of Molecular Evolution · doi:10.1007/s00239-009-9252-3 · Cited by 38
The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review
Spano, M. (2015) · Functional Neurology · doi:10.11138/fneur/2015.30.3.151 · Cited by 36
Autophagy and Human Neurodegenerative Diseases—A Fly’s Perspective
Kim, M., Ho, A., & Lee, J. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071596 · Cited by 35
Vimar Is a Novel Regulator of Mitochondrial Fission through Miro
Ding, L., Ye, L., Han, Y., Li, Y., Ji, X., & Liu, L. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006359 · Cited by 36
Lee, J. J., Andreazza, S., & Whitworth, A. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59647-3 · Cited by 36
Self-citationOxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons
Schwartzentruber, A., Boschian, C., Lopes, F. M., Myszczynska, M. A., New, E. J., Beyrath, J., Smeitink, J. A. M., Ferraiuolo, L., & Mortiboys, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-72345-4 · Cited by 36
Chen, J., Xue, J., Ruan, J., Zhao, J., Tang, B., & Duan, R. (2017) · The FASEB Journal · doi:10.1096/fj.201700011r · Cited by 35
Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease
Pirooznia, S. K., Wang, H., Panicker, N., Kumar, M., Neifert, S., Dar, M. A., Lau, E., Kang, B. G., Redding‐Ochoa, J., Troncoso, J. C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh1824 · Cited by 34
Diversity in the Regulation of Autophagy and Mitophagy: Lessons from Parkinson's Disease
Chu, C. T. (2011) · Parkinson s Disease · doi:10.4061/2011/789431 · Cited by 34
Cao, X., Wang, H., Wang, Z., Wang, Q., Zhang, S., Deng, Y., & Fang, Y. (2017) · Aging Cell · doi:10.1111/acel.12654 · Cited by 36
Detrimental deletions: mitochondria, aging and Parkinson's disease
Biskup, S., & Moore, D. J. (2006) · BioEssays · doi:10.1002/bies.20471 · Cited by 35
Induction of parkin expression in the presence of oxidative stress
Yang, Y., Muqit, M. M. K., & Latchman, D. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04998.x · Cited by 34
Gene therapy targeting mitochondrial pathway in Parkinson’s disease
Choong, C., & Mochizuki, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1616-4 · Cited by 34
Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder
Vecchia, E. D., Mortimer, N., Palladino, V. S., Kittel‐Schneider, S., Lesch, K., Reif, A., Schenck, A., & Norton, W. (2018) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000211 · Cited by 36
Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila
Fernandes, C., & Rao, Y. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-17 · Cited by 38
Protein recycling pathways in neurodegenerative diseases
Fecto, F., Esengul, Y. T., & Siddique, T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt243 · Cited by 34
Drosophila melanogaster as a Model of Muscle Degeneration Disorders
Kreipke, R. E., Kwon, Y. V., Shcherbata, H. R., & Ruohola‐Baker, H. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.003 · Cited by 36
Common Principles and Specific Mechanisms of Mitophagy from Yeast to Humans
Kumar, R., & Reichert, A. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094363 · Cited by 33
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00475-y · Cited by 34
Self-citationThe ER protein Creld regulates ER-mitochondria contact dynamics and respiratory complex 1 activity
Paradis, M., Kucharowski, N., Edwards‐Faret, G., Palacios, S. J. M., Meyer, C., Stümpges, B., Jamitzky, I., Kalinowski, J., Thiele, C., Bauer, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0155 · Cited by 33
Therapeutic Antiaging Strategies
Mishra, S. K., Balendra, V., Esposto, J., Obaid, A. A., Maccioni, R. B., Jha, N. K., Perry, G. L., Moustafa, M., Al-Shehri, M., Singh, M. P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102515 · Cited by 34
Animal models of mitochondrial DNA transactions in disease and ageing
Oliveira, M. T., Garesse, R., & Kaguni, L. S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.019 · Cited by 33
p32 regulates mitochondrial morphology and dynamics through parkin
Li, Y., Wan, O. W., Xie, W., & Chung, K. K. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.003 · Cited by 33
Bhalerao, S., & Clandinin, T. R. (2012) · Science · doi:10.1126/science.1223812 · Cited by 34
Structure-based design and characterization of Parkin-activating mutations
Stevens, M., Croteau, N., Eldeeb, M. A., Antico, O., Zeng, Z. W., Toth, R. L., Durcan, T. M., Springer, W., Fon, E. A., Muqit, M. M. K., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201419 · Cited by 33
Pathologic and therapeutic implications for the cell biology of parkin
Charan, R. A., & LaVoie, M. J. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.02.008 · Cited by 32
Models for LRRK2-Linked Parkinsonism
Li, T., Yang, D., Sushchky, S., Liu, Z., & Smith, W. W. (2011) · Parkinson s Disease · doi:10.4061/2011/942412 · Cited by 33
Nagle, M. W., Latourelle, J. C., Labadorf, A. T., Dumitriu, A., Hadzi, T. C., Beach, T. G., & Myers, R. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160925 · Cited by 32
Shimura, T., Sasatani, M., Kawai, H., Kamiya, K., Kobayashi, J., Komatsu, K., & Kunugita, N. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1387697 · Cited by 32
Bar, S., Prasad, M., & Datta, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.036954 · Cited by 34
Wang, M., Wan, C., He, T., Han, C., Zhu, K., Waddington, J. L., & Zhen, X. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108360 · Cited by 33
Huang, Y., Wan, Z., Tang, Y., Xu, J., Laboret, B., Nallamothu, S., Yang, C., Liu, B., Lu, R. O., Lu, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30178-x · Cited by 33
Programmed cell death and new discoveries in the genetics of parkinsonism
Burke, R. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05106.x · Cited by 33
Twyning, M. J., Tufi, R., Gleeson, T. P., Kolodziej, K. M., Campesan, S., Terriente-Félix, A., Collins, L., Lazzari, F. D., Giorgini, F., & Whitworth, A. J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113681 · Cited by 31
Self-citationvan der Merwe, C., Loos, B., Swart, C., Kinnear, C. J., Henning, F., van der Merwe, L., Pillay, K., Muller, N., Zaharie, D., Engelbrecht, L., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.151 · Cited by 31
Ubiquitination at the mitochondria in neuronal health and disease
Covill‐Cooke, C., Howden, J. H., Birsa, N., & Kittler, J. T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.003 · Cited by 33
Inhibition of the deubiquitinase USP8 corrects a Drosophila PINK1 model of mitochondria dysfunction
von Stockum, S., Sanchez-Martinez, A., Corrà, S., Chakraborty, J., Marchesan, E., Locatello, L., Da Rè, C., Cusumano, P., Caicci, F., Ferrari, V., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900392 · Cited by 30
Self-citationLoss of STING in parkin mutant flies suppresses muscle defects and mitochondria damage
Moehlman, A. T., Kanfer, G., & Youle, R. J. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010828 · Cited by 32
Sánchez-Martínez, Á., Martinez, A., & Whitworth, A. J. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002244 · Cited by 32
Self-citationNeuroproteomics as a promising tool in Parkinson’s disease research
Pienaar, I. S., Daniels, W. M. U., & Götz, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0070-3 · Cited by 32
Recent advances in using Drosophila to model neurodegenerative diseases
Lu, B. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0347-5 · Cited by 35
Huang, Z., Ren, S., Jiang, Y., & Wang, T. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.82 · Cited by 32
Using Drosophila as a platform for drug discovery from natural products in Parkinson's disease
Maitra, U., & Ciesla, L. M. (2019) · MedChemComm · doi:10.1039/c9md00099b · Cited by 31
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss
Biosa, A., Sánchez-Martínez, Á., Filograna, R., Terriente-Félix, A., Alam, S. M., Beltramini, M., Bubacco, L., Bisaglia, M., & Whitworth, A. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy069 · Cited by 32
Self-citationMitochondrial Targeting in Neurodegeneration: A Heme Perspective
Fiorito, V., Chiabrando, D., & Tolosano, E. (2018) · Pharmaceuticals · doi:10.3390/ph11030087 · Cited by 31
Vos, M. H., & Klein, C. (2021) · Cells · doi:10.3390/cells10030579 · Cited by 32
Mitochondrial dysfunction in Parkinson’s disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750811040032 · Cited by 30
Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress
Yu, F., & Zhou, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.052 · Cited by 30
Drosophila melanogaster LRPPRC2 is involved in coordination of mitochondrial translation
Baggio, F., Bratić, A. M., Mourier, A., Kauppila, T. E. S., Tain, L. S., Kukat, C., Habermann, B. H., Partridge, L., & Larsson, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1132 · Cited by 30
Trudler, D., Nash, Y., & Frenkel, D. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1399-z · Cited by 31
Mitochondrial Morphogenesis, Distribution, and Parkinson Disease
Yang, Y., & Lu, B. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b2048c · Cited by 31
Gawęda-Walerych, K., & Żekanowski, C. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1931 · Cited by 30
Central Parkin: The evolving role of Parkin in the heart
Dorn, G. W. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.014 · Cited by 30
The impact of genetic research on our understanding of Parkinson’s disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83002-x · Cited by 32
Srivastav, S., Singh, S. K., Yadav, A. K., & Srikrishna, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.106 · Cited by 29
A yeast model of the Parkinson׳s disease-associated protein Parkin
Pereira, C., Costa, V., Martins, L. M., & Saraiva, L. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.02.018 · Cited by 31
AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease
Haskin, J., Szargel, R., Shani, V., Mekies, L. N., Rott, R., Lim, G. G. Y., Lim, K., Bandopadhyay, R., Wolosker, H., & Engelender, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt058 · Cited by 29
A Simple One-step Dissection Protocol for Whole-mount Preparation of Adult Drosophila Brains
Tito, A. J., Cheema, S., Jiang, M., & Zhang, S. (2016) · Journal of Visualized Experiments · doi:10.3791/55128 · Cited by 29
Flies as the ointment: Drosophila modeling to enhance drug discovery
Bell, A. J., McBride, S. M. J., & Dockendorff, T. C. (2009) · Fly · doi:10.4161/fly.3.1.7774 · Cited by 30
Su, Y., Duan, J., Ying, Z., Hou, Y., Zhang, Y., Wang, R., & Deng, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.045 · Cited by 29
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Yip, J., Chiang, G. S. H., Lee, I. C. J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L. Y.-T., Teo, D. W. X., Seah, G. T., & Lehming, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010364 · Cited by 30
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Rodolfo, C., Ciccosanti, F., Giacomo, G. D., Piacentini, M., & Fimia, G. M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.43 · Cited by 29
The Power and Richness of Modelling Tauopathies in Drosophila
Papanikolopoulou, K., & Skoulakis, E. M. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8193-1 · Cited by 29
Murphy, K. T., & Lynch, G. S. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13312 · Cited by 27
Afsheen, S., Rehman, A. S., Jamal, A., Khan, N. H., & Parvez, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102340 · Cited by 28
Organelle aging: Lessons from model organisms
Bouska, M. J., Huang, K., Kang, P., & Bai, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.03.011 · Cited by 27
Terriente-Félix, A., Wilson, E. L., & Whitworth, A. J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008844 · Cited by 27
Self-citationAlgarzae, N. K., Hebron, M. L., Miessau, M., & Moussa, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.057 · Cited by 29
Pallanck, L. J., & Greenamyre, J. T. (2006) · Nature · doi:10.1038/4411058a · Cited by 29
Self-citationZhang, J., Liu, L., Xue, Y., Ma, Y., Liu, X., Li, Z., Li, Z., & Liu, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00092 · Cited by 27
Rings, chains and ladders: ubiquitin goes to work in the neuron
Johnston, J. A. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.004 · Cited by 28
Exercise is muscle mitochondrial medicine
Oliveira, A. N., Richards, B. J., Slavin, M., & Hood, D. A. (2021) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000250 · Cited by 26
Au, W. H., Miller‐Fleming, L., Sánchez-Martínez, Á., Lee, J., Twyning, M. J., Prag, H. A., Raik, L., Allen, S. P., Shaw, P. J., Ferraiuolo, L., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402853 · Cited by 27
Self-citationGene therapy: a viable therapeutic strategy for Parkinson’s disease?
Berry, A. L., & Foltynie, T. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5796-9 · Cited by 26
Mitochondrial Acetylation and Genetic Models of Parkinson's Disease
Auburger, G. W. J., Gispert, S., & Jendrach, M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00006-4 · Cited by 27
Melatonin prevents sepsis-induced renal injury via the PINK1/Parkin1 signaling pathway
Dai, W., Huang, H., Si, L., Hu, S., Zhou, L., Xu, L., & Deng, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4306 · Cited by 26
A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics
Maddison, D. C., Alfonso-Núñez, M., Swaih, A. M., Breda, C., Campesan, S., Allcock, N., Straatman-Iwanowska, A. A., Kyriacou, C. P., & Giorgini, F. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009129 · Cited by 30
Parkin: a potential target to promote healthy ageing
Leduc‐Gaudet, J., Hussain, S. N. A., & Gouspillou, G. (2022) · The Journal of Physiology · doi:10.1113/jp282567 · Cited by 27
Srivastav, S., Singh, S. K., Yadav, A. K., & Srikrishna, S. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1598-x · Cited by 26
Prospects for gene therapy in inherited neurodegenerative diseases
Cardone, M. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32809f97ff · Cited by 26
Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36
Abumrad, N. A., & Moore, D. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59219 · Cited by 26
Transcriptome Profiling Following Neuronal and Glial Expression of ALS-Linked SOD1 inDrosophila
Kumimoto, E. L., Fore, T. R., & Zhang, B. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.005850 · Cited by 28
Molecular Mechanisms of PINK1-Related Neurodegeneration
Pogson, J. H., Ivatt, R. M., & Whitworth, A. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0187-x · Cited by 26
Self-citationKaas, G. A., Kasuya, J., Lansdon, P., Ueda, A., Iyengar, A. S. R., Wu, C., & Kitamoto, T. (2016) · eNeuro · doi:10.1523/eneuro.0221-16.2016 · Cited by 27
Dung, V. M., & Thảo, Đ. T. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_4 · Cited by 26
Mitochondrial haplotypes affect metabolic phenotypes in the Drosophila Genetic Reference Panel
Bevers, R. P. J., Litovchenko, M., Kapopoulou, A., Braman, V. S., Robinson, M. R., Auwerx, J. H., Hollis, B., & Deplancke, B. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0147-3 · Cited by 26
The relationship between parkin and protein aggregation in neurodegenerative diseases
Khandelwal, P. J. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00015 · Cited by 26
Genetics of neurological disorders
Faghihi, M. A., Mottagui‐Tabar, S., & Wahlestedt, C. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.3.317 · Cited by 26
Liao, J. Z., Chung, H.-L., Shih, C. R. Y., Wong, K. K. L., Dutta, D., Nil, Z., Burns, C. G., Kanca, O., Park, Y.-J., Zuo, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47623-8 · Cited by 27
Altered Expression of DJ-1 and PINK1 in Sporadic ALS and in the SOD1G93AALS Mouse Model
Knippenberg, S., Sipos, J., Thau‐Habermann, N., Körner, S., Rath, K. J., Dengler, R., & Petri, S. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000004 · Cited by 25
RNA metabolism in the pathogenesis of Parkinson׳s disease
Lu, B., Gehrke, S., & Wu, Z. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.003 · Cited by 25
Ren, Z., Yang, N., Ji, C., Zheng, J., Wang, T., Liu, Y., & Zuo, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.030 · Cited by 25
Wu, S., Tan, K. J., Govindarajan, L. N., Stewart, J. C., Gu, L., Ho, J., Katarya, M., Wong, B. H., Tan, E., Li, D., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000346 · Cited by 25
Metadata
- Authors
- Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Department of Genome Sciences, University of Washington, P.O. Box 357730, Seattle, WA 98195; and Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-03-17
- Volume
- 100
- Issue
- 7
- Pages
- 4078-4083
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC153051
- OpenAlex
- W2055124287
- Cited by
- 1,203
- References
- 34
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 34 · 2023: 38 · 2022: 49 · 2021: 64 · 2020: 68 · 2019: 50 · 2018: 64 · 2017: 54 · 2016: 69 · 2015: 56 · 2014: 55 · 2013: 64 · 2012: 67
- FWCI
- 27.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS041780, 1R01NS41780-01, 1R01NS41536-01, R01NS041536)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkin, Parkinson's disease, autosomal recessive juvenile parkinsonism, mitochondrial dysfunction, muscle degeneration, apoptosis, Drosophila model, ubiquitin-protein ligase, spermatid individualization, male sterility, locomotion defects, lifespan, selective cell death
- MeSH terms
- Amino Acid Sequence, Animals, Cloning, Molecular, Drosophila, Ligases, Longevity, Male, Mitochondria, Molecular Sequence Data, Nerve Degeneration, Parkinson Disease, Recombinant Proteins, Spermatids, Mutagenesis, Sequence Alignment, Apoptosis, Sequence Homology, Amino Acid, Muscle, Skeletal, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review